Debated in Parliament on 14 Feb 2022.
Mr Patrick Tay Teck Guan asked the Minister for Health whether the Ministry will consider including atrial fibrillation as a chronic condition under the Chronic Disease Management Programme for MediSave to be utilised for drugs such as apixaban, for treating this condition.
Patients diagnosed with atrial fibrillation arising from a condition under the Chronic Disease Management Programme (CDMP), such as hypertension, can use MediSave for their treatment, including medications such as apixaban. However, atrial fibrillation, as a stand-alone condition, is currently not under CDMP.
CDMP conditions are regularly reviewed in consultation with the CDMP Clinical Advisory Committee (CAC) and based on considerations, such as disease burden, effectiveness of early intervention to reduce complications and availability of clear clinical treatment guidelines. We will take atrial fibrillation into account in our next review.
PAPERCUTS